High efficacy of 14-day high-dose PPI bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication in high clarithromycin resistance areas: A double blinded-randomized placebo-controlled study

被引：0
|
作者：
Poonyam, P. [1 ,2 ]
Vilaichone, R. [2 ,3 ,4 ]
Chotivitayatarakorn, P. [2 ,3 ,4 ]
Mahachai, V. [3 ]
机构：
[1] Srinakharinwirot Univ, Gastroenterol Unit, Fac Med, Nakorn Nayok, Thailand
[2] Thammasat Univ Hosp, Gastroenterol Unit, Pathum Thani, Thailand
[3] Natl Digest Dis Res Ctr Thailand, Pathum Thani, Thailand
[4] Thammasat Univ, CICM, Dept Med, Pathum Thani, Thailand
来源：
HELICOBACTER | 2019年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W3.2
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
    Sun, Qinjuan
    Liang, Xiao
    Zheng, Qing
    Liu, Wenzhong
    Xiao, Shudong
    Gu, Weiqi
    Lu, Hong
    [J]. HELICOBACTER, 2010, 15 (03) : 233 - 238
  • [2] HIGH EFFICACY OF 14-DAY VONOPRAZAN-BASED QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN AREAS WITH HIGH CLARITHROMYCIN RESISTANCE: A PROSPECTIVE RANDOMIZED STUDY (VQ-HP TRIAL)
    Tungtrongchitr, Nuttapat
    Pornthisarn, Bubpha
    Chonprasertsuk, Soonthorn
    Siramolpiwat, Sith
    Bhanthumkomol, Patommatat
    Nunanan, Pongjarat
    Issariyakulkarn, Navapan
    Mahachai, Varocha
    Vilaichone, Ratha-Korn
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S871 - S871
  • [3] High efficacy of 7-day and 14-day vonoprazan-based quadruple therapy for Helicobacter pylori eradication in areas with high clarithromycin resistance: A prospective randomized study (VQ-HP trial)
    Tungtrongchitr, N.
    Pornthisarn, B.
    Cholprasertsuk, S.
    Siramolpiwat, S.
    Bhanthumkomol, P.
    Nunanun, P.
    Issariyakulkarn, N.
    Eiamsitrakoon, T.
    Mahachai, V.
    Vilaichone, R. K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 36 - 36
  • [4] High Efficacy of 14-Day Standard Triple Therapy Plus Bismuth With Probiotic Supplement for H-pylori Eradication in Low Clarithromycin Resistance Areas
    Srinarong, Chanagune
    Mahachai, Varocha
    Vilaichone, Ratha-korn
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S391 - S391
  • [5] Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication
    Kim, Ji Yeon
    Lee, Sun-Young
    Kim, Jeong Hwan
    Sung, In-Kyung
    Park, Hyung Seok
    [J]. HELICOBACTER, 2020, 25 (02)
  • [6] NON-BISMUTH QUADRUPLE (CONCOMITANT) THERAPY FOR ERADICATION OF H. PYLORI: STANDARD VERSUS OPTIMIZED (14-DAY, HIGH-DOSE PPI) REGIMEN
    Gisbert, J. P.
    Harb, Y.
    Molina-Infante, J.
    Modolell, I.
    Anton, R.
    Bermejo, F.
    Barenys, M.
    Perez-Aisa, A.
    Rodrigo, L.
    Ortuno, J.
    Cosme, A.
    Almela, P.
    Alcedo, J.
    Fernandez-Bermejo, M.
    Marin, A. C.
    McNicholl, A. G.
    [J]. HELICOBACTER, 2013, 18 : 127 - 128
  • [7] High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis
    Wang, Hui
    Kong, Qing Zhou
    Li, Yue Yue
    Yang, Xiao Yun
    Zuo, Xiu Li
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (03) : 163 - 175
  • [8] Non-Bismuth Quadruple (Concomitant) Therapy for Eradication of H-pylori: Standard vs. Optimized (14-Day, High-Dose PPI) Regimen
    Gisbert, Javier P.
    Molina-Infante, Javier
    Harb, Yamal
    Bermejo, Fernando
    Modolell, Ines
    Aisa, Angeles Perez
    Barenys, Merce
    Anton, Rosario
    Barrio, Jesus
    Ortuno, Juan A.
    Rodrigo, Luis
    Almela, Pedro
    Pozzati, Liliana
    Tomas, Albert
    Huerta, Alain
    Alcedo, J.
    Algaba, Alicia
    Moreno, Nuria Fernandez
    Bermejo, Miguel Fernandez
    Marin, Alicia C.
    McNicholl, Adrian G.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S394 - S395
  • [9] Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial
    Mei, Hao
    Guo, Yan
    Zhao, Jing-Tao
    Yang, Jun
    Sun, Wen-jing
    Zhang, De-kui
    He, Ping
    Shi, Gang
    Su, Na-yun
    Han, Ran
    Lan, Chun-Hui
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [10] Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial
    Liu, Dan-Ni
    Wang, Qiu-Yan
    Li, Pei -Yuan
    Wu, Dong-Han
    Pan, Jing
    Chen, Zheng-Yi
    Li, Yan-Qiang
    Han, Xiang-Yang
    Lan, Cheng
    Tang, Jing
    Tan, Yan
    Mo, Cui-Yi
    Yang, Wei-Zhong
    Han, Jun-Ling
    Huang, Xiao-Xi
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (05)
12345